Literature DB >> 21363911

Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.

Xun Jin1, Hee-Young Jeon, Kyeung Min Joo, Jun-Kyum Kim, Juyoun Jin, Sung Hak Kim, Bong Gu Kang, Samuel Beck, Se Jeong Lee, Joong Kyu Kim, Ae-Kyung Park, Woong-Yang Park, Yun-Jaie Choi, Do-Hyun Nam, Hyunggee Kim.   

Abstract

One of the most detrimental hallmarks of glioblastoma multiforme (GBM) is cellular invasiveness, which is considered a potential cause of tumor recurrence. Infiltrated GBM cells are difficult to completely eradicate surgically and with local therapeutic modalities. Although much effort has focused on understanding the various mechanisms controlling GBM invasiveness, its nature remains poorly understood. In this study, we established highly serial intracranial transplantation. U87R4 cells were highly invasive and displayed stem cell-like properties, as compared to noninvasive but proliferative U87L4 cells. Microarray analysis during serial transplantation revealed that apoptosis-inducing genes (caspase3 and PDCD4) were downregulated whereas several cancer stem cell-relevant genes [Frizzled 4 (FZD4) and CD44] were upregulated in more invasive cells. U87R4 cells were resistant to anticancer drug-induced cell death, partly due to downregulation of caspase3 and PDCD4, and they retained activated Wnt/β-catenin signaling due to upregulation of Frizzled 4, which was sufficient to control neurosphere formation. We also found that FZD4 promoted expression of the epithelial to mesenchymal transition regulator SNAI1, along with acquisition of a mesenchymal phenotype. Taken together, our results argue that Frizzled 4 is a member of the Wnt signaling family that governs both stemness and invasiveness of glioma stem cells, and that it may be a major cause of GBM recurrence and poor prognosis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21363911     DOI: 10.1158/0008-5472.CAN-10-1495

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  74 in total

Review 1.  Wnt/beta-catenin signaling in glioma.

Authors:  Kailiang Zhang; Junxia Zhang; Lei Han; Peiyu Pu; Chunsheng Kang
Journal:  J Neuroimmune Pharmacol       Date:  2012-03-28       Impact factor: 4.147

2.  Upregulation of circulating cancer stem cell marker, DCLK1 but not Lgr5, in chemoradiotherapy-treated colorectal cancer patients.

Authors:  Alireza Mirzaei; Gholamreza Tavoosidana; Mohammad Hossein Modarressi; Afshin Abdi Rad; Mohammad Sadegh Fazeli; Reza Shirkoohi; Masoumeh Tavakoli-Yaraki; Zahra Madjd
Journal:  Tumour Biol       Date:  2015-01-29

Review 3.  GPCRs and cancer.

Authors:  Rosamaria Lappano; Marcello Maggiolini
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

4.  LEF1 regulates glioblastoma cell proliferation, migration, invasion, and cancer stem-like cell self-renewal.

Authors:  Xingchun Gao; Yajing Mi; Yue Ma; Weilin Jin
Journal:  Tumour Biol       Date:  2014-08-16

Review 5.  Glioblastoma stem cells: Molecular characteristics and therapeutic implications.

Authors:  Nermin Sumru Bayin; Aram Sandaldjian Modrek; Dimitris George Placantonakis
Journal:  World J Stem Cells       Date:  2014-04-26       Impact factor: 5.326

6.  Wnt/β-catenin signaling is a key downstream mediator of MET signaling in glioblastoma stem cells.

Authors:  Kang Ho Kim; Ho Jun Seol; Eun Hee Kim; Jinguen Rheey; Hyun Jin Jin; Yeri Lee; Kyeung Min Joo; Jeongwu Lee; Do-Hyun Nam
Journal:  Neuro Oncol       Date:  2012-12-20       Impact factor: 12.300

7.  Heterogeneous nuclear ribonucleoprotein C1/C2 controls the metastatic potential of glioblastoma by regulating PDCD4.

Authors:  Young Mi Park; Su Jin Hwang; Kiyoshi Masuda; Kyung-Min Choi; Mi-Ran Jeong; Do-Hyun Nam; Myriam Gorospe; Hyeon Ho Kim
Journal:  Mol Cell Biol       Date:  2012-08-20       Impact factor: 4.272

8.  Identification and characterization of a small-molecule inhibitor of Wnt signaling in glioblastoma cells.

Authors:  Alessandra De Robertis; Silvia Valensin; Marco Rossi; Patrizia Tunici; Margherita Verani; Antonella De Rosa; Cinzia Giordano; Maurizio Varrone; Arianna Nencini; Carmela Pratelli; Tiziana Benicchi; Annette Bakker; Jeffrey Hill; Kanda Sangthongpitag; Vishal Pendharkar; Boping Liu; Fui Mee Ng; Siew Wen Then; Shi Jing Tai; Seong-Moon Cheong; Xi He; Andrea Caricasole; Massimiliano Salerno
Journal:  Mol Cancer Ther       Date:  2013-04-25       Impact factor: 6.261

9.  Tumor-initiating cells and FZD8 play a major role in drug resistance in triple-negative breast cancer.

Authors:  Shuping Yin; Liping Xu; R Daniel Bonfil; Sanjeev Banerjee; Fazlul H Sarkar; Seema Sethi; Kaladhar B Reddy
Journal:  Mol Cancer Ther       Date:  2013-02-27       Impact factor: 6.261

10.  Wnt pathway activity confers chemoresistance to cancer stem-like cells in a neuroblastoma cell line.

Authors:  Sharada D Vangipuram; Steven A Buck; William D Lyman
Journal:  Tumour Biol       Date:  2012-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.